Related Experiment Video

Updated: Aug 7, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung

W G North1, J Du

  • 1Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA. William.G.North@dartmouth.edu

Peptides
|January 8, 1999
PubMed

Insights

Variant small-cell lung cancer (SCCL) retains enzymes for neuropeptide production. This suggests potential therapeutic targets despite drug resistance and loss of other markers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Small-cell lung cancer (SCCL) is a neuroendocrine tumor.
  • SCCL can dedifferentiate into a drug-resistant form, losing markers like neuron-specific enolase (NSE) and dopa decarboxylase (DDC).
  • Neuropeptides act as autocrine growth factors for SCCL.

Purpose of the Study:

  • To investigate if drug-resistant SCCL (NCI H82 cell line) retains the capacity to generate active neuropeptides.
  • To determine if key enzymes for neuropeptide synthesis, including prohormone convertases (PCs), carboxypeptidases (CPs), and peptidylglycine a-amidating monooxygenase (PAM), are expressed in variant SCCL.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect mRNAs for PC1, PC2, CPE, and PAM in NCI H82 cells.
  • Primers were designed for specific amplification and sequencing of target enzyme mRNAs.
  • Western blot analysis was performed using antibodies against PC1, PC2, CPE, and PAM to confirm protein expression.

Main Results:

  • RT-PCR successfully amplified and sequenced mRNAs for PC1, PC2, CPE, and PAM, confirming their presence and structure in NCI H82 cells.
  • Western blot analysis provided evidence that these mRNAs are translated into functional proteins.
  • These key enzymes for neuropeptide generation remain expressed in variant SCCL, unlike NSE and DDC.

Conclusions:

  • Variant SCCL expresses essential enzymes (PC1, PC2, CPE, PAM) required for generating active neuropeptides.
  • This expression persists despite dedifferentiation and drug resistance, contrasting with the loss of NSE and DDC.
  • The continued expression of these enzymes suggests they may play a role in the biology of drug-resistant SCCL and could be potential therapeutic targets.

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Signal Sequences and Sorting Receptors01:41

Signal Sequences and Sorting Receptors

Signal sequences are short amino acid sequences that guide newly synthesized proteins to their proper location within the cell. Classical signal sequences are fifteen to sixty amino acids long and present at the N-terminus of a polypeptide chain. Each signal sequence has a conserved segment of basic residues towards their N terminus, a hydrophobic core, and a C-terminus rich in polar residues. The C-terminus also contains a signal cleavage site and features a -3 -1 sequence motif. The -3-1...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...